The capillary blood collection devices market size has grown rapidly in recent years. It will grow from $2.72 billion in 2025 to $3.07 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in routine diagnostic testing, widespread use of fingerstick glucose testing, expansion of hospital and diagnostic laboratories, increasing prevalence of chronic diseases, rising demand for pediatric and neonatal testing.
The capillary blood collection devices market size is expected to see rapid growth in the next few years. It will grow to $4.68 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growth in home-based diagnostic testing, rising demand for decentralized healthcare, increasing adoption of rapid diagnostic tests, expansion of preventive health screening programs, growing use of capillary samples in advanced diagnostics. Major trends in the forecast period include rising adoption of minimally invasive blood collection, increasing demand for point-of-care sample collection, growing use of capillary sampling in home diagnostics, expansion of dried blood spot testing applications, increased focus on patient comfort and safety devices.
The rising prevalence of chronic diseases is anticipated to drive the growth of the capillary blood collection devices market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing monitoring and treatment. The growing prevalence of chronic diseases is driven by factors such as aging populations, unhealthy lifestyles, environmental influences, and advancements in medical diagnostics that enable earlier and more accurate detection. Capillary blood collection devices help patients and healthcare providers better manage chronic conditions by enabling frequent, convenient, and minimally invasive blood testing. This supports improved disease management, patient outcomes, and overall quality of life. For instance, in April 2024, according to Allergy UK, a UK-based national charity, more than 21 million people in the UK were affected by allergies, which became the most commonly reported chronic health condition in 2022, and forecasts suggest that by 2026, half of Europe’s population will experience at least one allergy. Therefore, the increasing prevalence of chronic diseases is driving the growth of the capillary blood collection devices market.
Major players in the capillary blood collection devices market are concentrating on developing innovative products tailored to specific needs and challenges in healthcare settings, particularly for infants and young children. For example, in October 2023, Owen Mumford Ltd. introduced Unistik Heelstik, a range of capillary blood sampling devices designed for neonates and children. This range includes four instruments, each suited for a specific developmental stage, Unistik Heelstik Toddler, Full Term, Preemie, and Micro Preemie. These devices aim to address the challenges of capillary blood sampling in newborns and older babies, ensuring acceptable sample volumes while minimizing discomfort for the baby. The Unistik Heelstik devices target only surface blood vessels, avoiding penetration deep enough to stimulate skin pain fibers.
In May 2025, Neoteryx, the microsampling product brand of Trajan Scientific and Medical and a US-based provider of volumetric absorptive microsampling (VAMS) capillary blood collection devices, entered into a partnership with Cellecta, Inc., a company offering targeted RNA expression profiling assays and next-generation sequencing solutions. Through this collaboration, the companies sought to integrate Neoteryx’s Mitra® VAMS capillary blood microsampling devices with Cellecta’s DriverMap™ EXP Human Genome-Wide 19K Dried Blood Microsample Profiling Kit to facilitate easy at-home finger-prick capillary blood collection and comprehensive whole-genome expression analysis. This partnership supports broader adoption of capillary blood collection devices in decentralized research, longitudinal studies, and biomarker discovery within the capillary blood collection devices market. Cellecta, Inc. is a U.S.-based provider of genomic products and services focused on drug target identification and biomarker discovery.
Major companies operating in the capillary blood collection devices market are Becton Dickinson and Company, Terumo Medical Corporation, Owen Mumford Ltd, Greiner Bio-One International GmbH, SARSTEDT AG & Co. KG, Nipro Corporation, Gerresheimer AG, Abbott Laboratories, F. Hoffmann-La Roche AG, HTL-STREFA S.A., Chengdu Rich Science Industry Co. Ltd, PTS Diagnostics, Vitrex Medical A/S, SteriLance Medical Suzhou Inc., Improve Medical Instruments Co. Ltd, Narang Medical Limited, Sekisui Medical Co. Ltd, Medline Industries LP, VitroCom Inc, FL Medical S.r.l.
North America was the largest region in the capillary blood collection devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capillary blood collection devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the capillary blood collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the capillary blood collection devices market by increasing costs for imported raw materials such as medical-grade plastics, stainless steel, and glass used in lancets and micro-container tubes. These cost pressures have been most pronounced for product segments such as safety lancets and micro-hematocrit tubes, with asia-pacific and europe being more exposed due to cross-border manufacturing and sourcing. Higher tariffs have slightly increased device prices and procurement costs for hospitals and diagnostic centers. However, tariffs have also encouraged local manufacturing and sourcing, supporting domestic production capacity and supply chain resilience.
The capillary blood collection devices market research report is one of a series of new reports that provides capillary blood collection devices market statistics, including capillary blood collection devices industry global market size, regional shares, competitors with a capillary blood collection devices market share, detailed capillary blood collection devices market segments, market trends and opportunities, and any further data you may need to thrive in the capillary blood collection devices industry. This capillary blood collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Capillary blood collection devices refer to medical instruments utilized for acquiring small blood samples via a minimally invasive method, typically from areas such as the fingertip, heel, or earlobe. These tools are engineered to puncture the skin minimally to extract a small quantity of capillary blood, which is then utilized for a range of diagnostic assessments.
The primary components of capillary blood collection devices include lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other related items. Lancets are small, sharp instruments employed to puncture the skin, extracting a small blood droplet for testing purposes. These devices incorporate a variety of materials such as plastic, glass, stainless steel, ceramic, among others, catering to a wide array of tests such as whole blood analysis, serum protein tests, comprehensive metabolic panel tests, liver function tests, and dried blood spot tests. These devices find utility in hospitals, clinics, blood donation centers, diagnostic facilities, home diagnostics, and pathology laboratories.
The capillary blood collection devices market consists of sales of blood transfer devices, blood collection systems, Lancets, micro sampling devices and warming devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The capillary blood collection devices market size is expected to see rapid growth in the next few years. It will grow to $4.68 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to growth in home-based diagnostic testing, rising demand for decentralized healthcare, increasing adoption of rapid diagnostic tests, expansion of preventive health screening programs, growing use of capillary samples in advanced diagnostics. Major trends in the forecast period include rising adoption of minimally invasive blood collection, increasing demand for point-of-care sample collection, growing use of capillary sampling in home diagnostics, expansion of dried blood spot testing applications, increased focus on patient comfort and safety devices.
The rising prevalence of chronic diseases is anticipated to drive the growth of the capillary blood collection devices market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing monitoring and treatment. The growing prevalence of chronic diseases is driven by factors such as aging populations, unhealthy lifestyles, environmental influences, and advancements in medical diagnostics that enable earlier and more accurate detection. Capillary blood collection devices help patients and healthcare providers better manage chronic conditions by enabling frequent, convenient, and minimally invasive blood testing. This supports improved disease management, patient outcomes, and overall quality of life. For instance, in April 2024, according to Allergy UK, a UK-based national charity, more than 21 million people in the UK were affected by allergies, which became the most commonly reported chronic health condition in 2022, and forecasts suggest that by 2026, half of Europe’s population will experience at least one allergy. Therefore, the increasing prevalence of chronic diseases is driving the growth of the capillary blood collection devices market.
Major players in the capillary blood collection devices market are concentrating on developing innovative products tailored to specific needs and challenges in healthcare settings, particularly for infants and young children. For example, in October 2023, Owen Mumford Ltd. introduced Unistik Heelstik, a range of capillary blood sampling devices designed for neonates and children. This range includes four instruments, each suited for a specific developmental stage, Unistik Heelstik Toddler, Full Term, Preemie, and Micro Preemie. These devices aim to address the challenges of capillary blood sampling in newborns and older babies, ensuring acceptable sample volumes while minimizing discomfort for the baby. The Unistik Heelstik devices target only surface blood vessels, avoiding penetration deep enough to stimulate skin pain fibers.
In May 2025, Neoteryx, the microsampling product brand of Trajan Scientific and Medical and a US-based provider of volumetric absorptive microsampling (VAMS) capillary blood collection devices, entered into a partnership with Cellecta, Inc., a company offering targeted RNA expression profiling assays and next-generation sequencing solutions. Through this collaboration, the companies sought to integrate Neoteryx’s Mitra® VAMS capillary blood microsampling devices with Cellecta’s DriverMap™ EXP Human Genome-Wide 19K Dried Blood Microsample Profiling Kit to facilitate easy at-home finger-prick capillary blood collection and comprehensive whole-genome expression analysis. This partnership supports broader adoption of capillary blood collection devices in decentralized research, longitudinal studies, and biomarker discovery within the capillary blood collection devices market. Cellecta, Inc. is a U.S.-based provider of genomic products and services focused on drug target identification and biomarker discovery.
Major companies operating in the capillary blood collection devices market are Becton Dickinson and Company, Terumo Medical Corporation, Owen Mumford Ltd, Greiner Bio-One International GmbH, SARSTEDT AG & Co. KG, Nipro Corporation, Gerresheimer AG, Abbott Laboratories, F. Hoffmann-La Roche AG, HTL-STREFA S.A., Chengdu Rich Science Industry Co. Ltd, PTS Diagnostics, Vitrex Medical A/S, SteriLance Medical Suzhou Inc., Improve Medical Instruments Co. Ltd, Narang Medical Limited, Sekisui Medical Co. Ltd, Medline Industries LP, VitroCom Inc, FL Medical S.r.l.
North America was the largest region in the capillary blood collection devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capillary blood collection devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the capillary blood collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the capillary blood collection devices market by increasing costs for imported raw materials such as medical-grade plastics, stainless steel, and glass used in lancets and micro-container tubes. These cost pressures have been most pronounced for product segments such as safety lancets and micro-hematocrit tubes, with asia-pacific and europe being more exposed due to cross-border manufacturing and sourcing. Higher tariffs have slightly increased device prices and procurement costs for hospitals and diagnostic centers. However, tariffs have also encouraged local manufacturing and sourcing, supporting domestic production capacity and supply chain resilience.
The capillary blood collection devices market research report is one of a series of new reports that provides capillary blood collection devices market statistics, including capillary blood collection devices industry global market size, regional shares, competitors with a capillary blood collection devices market share, detailed capillary blood collection devices market segments, market trends and opportunities, and any further data you may need to thrive in the capillary blood collection devices industry. This capillary blood collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Capillary blood collection devices refer to medical instruments utilized for acquiring small blood samples via a minimally invasive method, typically from areas such as the fingertip, heel, or earlobe. These tools are engineered to puncture the skin minimally to extract a small quantity of capillary blood, which is then utilized for a range of diagnostic assessments.
The primary components of capillary blood collection devices include lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other related items. Lancets are small, sharp instruments employed to puncture the skin, extracting a small blood droplet for testing purposes. These devices incorporate a variety of materials such as plastic, glass, stainless steel, ceramic, among others, catering to a wide array of tests such as whole blood analysis, serum protein tests, comprehensive metabolic panel tests, liver function tests, and dried blood spot tests. These devices find utility in hospitals, clinics, blood donation centers, diagnostic facilities, home diagnostics, and pathology laboratories.
The capillary blood collection devices market consists of sales of blood transfer devices, blood collection systems, Lancets, micro sampling devices and warming devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Capillary Blood Collection Devices Market Characteristics
3. Capillary Blood Collection Devices Market Supply Chain Analysis
4. Global Capillary Blood Collection Devices Market Trends and Strategies
5. Capillary Blood Collection Devices Market Analysis of End Use Industries
7. Global Capillary Blood Collection Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Capillary Blood Collection Devices Total Addressable Market (TAM) Analysis for the Market
9. Capillary Blood Collection Devices Market Segmentation
10. Capillary Blood Collection Devices Market Regional and Country Analysis
11. Asia-Pacific Capillary Blood Collection Devices Market
12. China Capillary Blood Collection Devices Market
13. India Capillary Blood Collection Devices Market
14. Japan Capillary Blood Collection Devices Market
15. Australia Capillary Blood Collection Devices Market
16. Indonesia Capillary Blood Collection Devices Market
17. South Korea Capillary Blood Collection Devices Market
18. Taiwan Capillary Blood Collection Devices Market
19. South East Asia Capillary Blood Collection Devices Market
20. Western Europe Capillary Blood Collection Devices Market
21. UK Capillary Blood Collection Devices Market
22. Germany Capillary Blood Collection Devices Market
23. France Capillary Blood Collection Devices Market
24. Italy Capillary Blood Collection Devices Market
25. Spain Capillary Blood Collection Devices Market
26. Eastern Europe Capillary Blood Collection Devices Market
27. Russia Capillary Blood Collection Devices Market
28. North America Capillary Blood Collection Devices Market
29. USA Capillary Blood Collection Devices Market
30. Canada Capillary Blood Collection Devices Market
31. South America Capillary Blood Collection Devices Market
32. Brazil Capillary Blood Collection Devices Market
33. Middle East Capillary Blood Collection Devices Market
34. Africa Capillary Blood Collection Devices Market
36. Capillary Blood Collection Devices Market Competitive Landscape and Company Profiles
37. Capillary Blood Collection Devices Market Other Major and Innovative Companies
40. Capillary Blood Collection Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Capillary Blood Collection Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses capillary blood collection devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for capillary blood collection devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The capillary blood collection devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Lancets; Micro-Container Tubes; Micro-Hematocrit Tubes; Warming Devices; Other Product2) By Materials: Plastic; Glass; Stainless Steel; Ceramic; Other Materials
3) By Application: Whole Blood; Serum Protein Tests; Comprehensive Metabolic Panel Tests; Liver Function Tests; Dried Blood Spot Tests
4) By End-Users: Hospitals And Clinics; Blood Donation Centers; Diagnostic Centers; Home Diagnosis; Pathology Laboratories
Subsegments:
1) By Lancets: Safety Lancets; Standard Lancets; Precision Lancets; Multi-Use Lancets2) By Micro-Container Tubes: Plastic Micro-Containers; Glass Micro-Containers; Capillary Blood Collection Tubes With Anticoagulants; Capillary Blood Collection Tubes For Serum
3) By Micro-Hematocrit Tubes: Plastic Micro-Hematocrit Tubes; Glass Micro-Hematocrit Tubes; Capillary Blood Collection Tubes For Hematocrit Testing
4) By Warming Devices: Thermal Warming Pads; Electric Warming Devices; Infrared Warming Devices; Handheld Warming Devices
5) By Other Products: Blood Collection Systems; Collection Caps And Caps For Microtubes; Blood Sample Storage Devices
Companies Mentioned: Becton Dickinson and Company; Terumo Medical Corporation; Owen Mumford Ltd; Greiner Bio-One International GmbH; SARSTEDT AG & Co. KG; Nipro Corporation; Gerresheimer AG; Abbott Laboratories; F. Hoffmann-La Roche AG; HTL-STREFA S.A.; Chengdu Rich Science Industry Co. Ltd; PTS Diagnostics; Vitrex Medical A/S; SteriLance Medical Suzhou Inc.; Improve Medical Instruments Co. Ltd; Narang Medical Limited; Sekisui Medical Co. Ltd; Medline Industries LP; VitroCom Inc; FL Medical S.r.l
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Capillary Blood Collection Devices market report include:- Becton Dickinson and Company
- Terumo Medical Corporation
- Owen Mumford Ltd
- Greiner Bio-One International GmbH
- SARSTEDT AG & Co. KG
- Nipro Corporation
- Gerresheimer AG
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- HTL-STREFA S.A.
- Chengdu Rich Science Industry Co. Ltd
- PTS Diagnostics
- Vitrex Medical A/S
- SteriLance Medical Suzhou Inc.
- Improve Medical Instruments Co. Ltd
- Narang Medical Limited
- Sekisui Medical Co. Ltd
- Medline Industries LP
- VitroCom Inc
- FL Medical S.r.l
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.07 Billion |
| Forecasted Market Value ( USD | $ 4.68 Billion |
| Compound Annual Growth Rate | 11.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
